DC Healthcare Holdings Berhad (has announced that the share allocation to the Malaysian public from the initial public offering has been oversubscribed by 59.46 times.
IPO involves the issuance of 199.26 million ordinary shares comprising a public issue of 49.81 million new shares and an offer for sale of 99.63 million existing shares. The IPO Shares were made available for application in the following manner. 49.81 million IPO Shares through balloting to the Malaysian public. 29.89 million IPO Shares to eligible directors and employees of the Group; and 119.56 million IPO Shares to selected investors
A total of 17,614 applications for 3,011,662,400 IPO Shares with a value of RM752,915,600.00 were received from the Malaysian public, representing an overall oversubscription rate of 59.46 times. Of this, a total of 7,509 applications for 1,052,785,400 IPO Shares were received for the Bumiputera portion, representing an oversubscription rate of 41.27 times. For the remaining Malaysian public portion, a total of 10,105 applications for 1,958,877,000 IPO Shares were received, representing an oversubscription rate of 77.65 times.
The 29.89 million IPO Shares made available for application by the eligible directors and employees were also fully subscribed.
Managing Director of DC Healthcare, Dr. Chong Tze Sheng said, “We would like to thank investors for their trust in DC Healthcare and the team behind it. Demand for aesthetic medical services is on the rise, appealing to different ages and genders. The success of our IPO will also ensure that our plans to expand our network of clinics will be expedited.”
DC Healthcare Holdings Berhad will be listed on the ACE Market of Bursa Malaysia Securities Berhad on 17 July 2023.
Tricor Investor & Issuing House Services Sdn. Bhd. is the Issuing House and M&A Securities Sdn Bhd, is the Principal Adviser, Sponsor, Underwriter and Placement Agent for the IPO exercise.
